Abstract:Intrahepatic cholangiocarcinoma (ICC), a type of bile duct cancer, has a high mortality rate. Gut microbiota, bile acid metabolism, and cytokines have not been characterized in patients with ICC, and better noninvasive diagnostic approaches for ICC are essential to be established. Accordingly, in this study, we aimed to improve our understanding of changes in gut microbiota, bile acid metabolism, and cytokines in patients with ICC. We found that the α‐ and β‐diversities of ICC were highest and that the abundances of four genera (Lactobacillus, Actinomyces, Peptostreptococcaceae, and Alloscardovia) were increased in patients with ICC compared with those in patients with hepatocellular carcinoma or liver cirrhosis and in normal individuals. The glycoursodeoxycholic acid and tauroursodeoxycholic acid (TUDCA) plasma‐stool ratios (PSRs) were obviously increased in patients with ICC. Furthermore, the genera Lactobacillus and Alloscardovia positively correlated with TUDCA‐PSR were combined to discriminate ICC from the other three diseases. Vascular invasion (VI) frequently led to a poor prognosis in patients with ICC. Compared with patients with ICC without VI, patients with VI had a greater abundance of the family Ruminococcaceae, increased levels of plasma interleukin (IL)‐4 and six conjugated bile acids, and decreased levels of plasma IL‐6 and chenodeoxycholic acid. A positive correlation between plasma taurocholic acid and IL‐4 was observed in patients with ICC. Plasma TUDCA was negatively correlated with the abundance of the genus Pseudoramibacter and the survival time of patients with ICC, but had no effect on tumor size, as determined in two murine tumor models. <h3 class="article-section__sub-title section1"> Conclusions</h3>In this study, we identified new biomarkers, including gut microbiota, bile acids, and inflammatory cytokines, for diagnosis of ICC and prediction of VI in patients with ICC.This article is protected by copyright. All rights reserved.

B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma

Integrated Bioinformatics Analysis and Clinical Validation Reveals That High Expression of Mucin 1 in Intrahepatic Cholangiocarcinoma Predicts Recurrence after Curative Resection.

Integrative Analyses Identify CD73 As a Prognostic Biomarker and Immunotherapeutic Target in Intrahepatic Cholangiocarcinoma.

Upregulation of B7-H4 Promotes Tumor Progression of Intrahepatic Cholangiocarcinoma

Association Between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma

Upregulated Expression of HOXB7 in Intrahepatic Cholangiocarcinoma is Associated with Tumor Cell Metastasis and Poor Prognosis

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence

High Expression of B7-H2 or B7-H3 is Associated with Poor Prognosis in Hepatocellular Carcinoma

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma

BIRC7 and STC2 Expression Are Associated with Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma

Expression of CD 133 in human intrahepatic cholangiocarcinoma : its relation with lymph node metastasis and poor prognosis

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma

Role of Eif3c Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma

High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study

Clinicopathological Characters and Prognostic Significance of Cytokeratins Expression in Intrahepatic Cholangiocarcinoma.

CK7/CK19 Index: A Potential Prognostic Factor for Postoperative Intrahepatic Cholangiocarcinoma Patients

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience

Expression and Clinical Significance of B7-H1 and B7-H3 in Ovarian Carcinoma

Identify bile acids metabolism-related biomarkers and prognostic factor in intrahepatic cholangiocarcinoma

Up-regulation of 14-3-3ζ Expression in Intrahepatic Cholangiocarcinoma and Its Clinical Implications